These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Outcome of azithromycin treatment of active trachoma in Omani school children.
    Author: Khandekarf R, Mohammed AJ.
    Journal: East Mediterr Health J; 2003; 9(5-6):1026-33. PubMed ID: 16450533.
    Abstract:
    A prospective cohort study was made of 386 first-grade primary-school children in Oman with active trachoma and 386 matched controls without trachoma. All children were educated about trachoma prevention. In addition, trachoma cases were treated with a single dose of oral azithromycin (20 mg/kg). Trachoma status was evaluated after 6 weeks, 6 months and 12 months. The follicles and inflammatory signs of active trachoma resolved 6 weeks or more after azithromycin treatment. The protection against subsequent trachoma infection cycles was optimal at 6 months (85.2% of cases, 99.0% of controls infection-free) but declined at 12 months (66.7% of cases, 98.2% of controls infection-free). Clinical evaluation seems to be a useful tool to evaluate the response of azithromycin to active trachoma cases in schoolchildren in a country with limited resources.
    [Abstract] [Full Text] [Related] [New Search]